Anthropometric Characterization of Impaired Fetal Growth Risk Factors for and Prognosis of Newborns With Stunting or Wzisting

Nenhuma Miniatura disponível
Citações na Scopus
50
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER MEDICAL ASSOC
Autores
VICTORA, Cesar G.
VILLAR, Jose
BARROS, Fernando C.
ISMAIL, Leila Cheikh
CHUMLEA, Cameron
PAPAGEORGHIOU, Aris T.
BERTINO, Enrico
OHUMA, Eric O.
LAMBERT, Ann
CARVALHO, Maria
Citação
JAMA PEDIATRICS, v.169, n.7, article ID e151431, 10p, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
IMPORTANCE Stunting (short length for age) and wasting (low body mass index [BMI] for age) are widely used to assess child nutrition. In contrast, newborns tend to be assessed solely based on their weight. OBJECTIVE WE To use recent international standards for newborn size by gestational age to assess how stunted and wasted newborns differ in terms of risk factors and prognoses. DESIGN, SETTING, AND PARTICIPANTS A cross-sectional study with follow-up until hospital discharge was conducted at urban sites in Brazil, China, India, Italy, Kenya, Oman, England, and the United States that are participating in the INTERGROWTH-21' Project. The study was conducted from April 27, 2009, to March 2, 2014, and the final dataset for analyses was locked on March 19, 2014. EXPOSURES Sociodemographic and behavioral maternal risk factors, previous pregnancy history, and maternal and fetal conditions during pregnancy were investigated as risk factors for stunting and wasting. Anthropometry at birth was used to predict for neonatal prognosis. MAIN OUTCOMES AND MEASURES Newborn stunting and wasting were defined as birth length and BlVlItor gestational age below the third centiles of the INTERGROWTH-21' standards. Prognosis was assessed through mortality before hospital discharge, admission to neonatal intensive care units, and newborn complications. RESULTS From the 60 206 singleton live births during the study period, we selected all newborns between 33 weeks' and 42 weeks 6 days' gestation at birth (51200 [85%]) with reliable ultrasound dating. Stunting affected 3.8% and wasting 3.4% of all newborns; both conditions were present in 0.7% of the sample. Of the 26 conditions studied, five were more strongly associated with stunting than with wasting (reported as odds ratios [OR]; 95% CO: short maternal height (6.7; 5.1-9.0), younger maternal age (0.7; 0.5-0.9), smoking (2.8; 2.3-3.3), illicit drug use (2.3; 1.5-3.6), and clinically suspected intrauterine growth restriction (5.2; 4.5-6.0). Wasting was more strongly related than stunting with 4 newborn outcomes (neonatal intensive care stay, 6.7 [5.5-8.1]; respiratory distress syndrome, 4.0 [3.3-4.9]; transient tachypnea, 2.1[1.5-2.9]; and no oral feeding for >24 hours, 5.0 [3.9-6.5]). Maternal gestational diabetes mellitus was protective against wasting (0.6; 0.5-0.8) but not against stunting (0.9; 0.7-1.1). CONCLUSIONS AND RELEVANCE Although newborn stunting and wasting share some common determinants, they are distinct phenotypes with their own risk factors and neonatal prognoses. To be consistent with the literature on infant and child nutrition, newborns should be classified using the 2 phenotypes of stunting and wasting. The distinction will help to prioritize preventive interventions and focus the management of fetal undernutrition.
Palavras-chave
Referências
  1. [Anonymous], PHYS STAT UINT ANT
  2. Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730
  3. Barros FC, 2015, JAMA PEDIATR, V169, P220, DOI 10.1001/jamapediatrics.2014.3040
  4. Bhutta ZA, 2013, BJOG-INT J OBSTET GY, V120, P56, DOI 10.1111/1471-0528.12312
  5. Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976
  6. de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27
  7. de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15
  8. Ismail LC, 2013, BJOG-INT J OBSTET GY, V120, P42, DOI 10.1111/1471-0528.12125
  9. Ismail LC, 2013, BJOG-INT J OBSTET GY, V120, P48, DOI 10.1111/1471-0528.12127
  10. Kramer M. S., 2001, Nutrition and health in developing countries, P57
  11. KRAMER MS, 1989, PEDIATRICS, V84, P717
  12. LUBCHENCO LO, 1963, PEDIATRICS, V32, P793
  13. Ohuma EO, 2013, BJOG-INT J OBSTET GY, V120, P64, DOI 10.1111/1471-0528.12080
  14. Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636
  15. Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
  16. Restrepo-Méndez MC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-781
  17. Rohrer F, 1921, MUNCHEN MED WOCHEN, V68, P580
  18. Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4
  19. Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519
  20. Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
  21. Villar J, 1982, Obstet Gynecol Surv, V37, P499, DOI 10.1097/00006254-198208000-00001
  22. Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047
  23. VILLAR J, 1984, PEDIATRICS, V74, P783
  24. Villar J, 2013, BJOG S, V120, pv
  25. Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6